These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Differential regulation of striatal preproenkephalin mRNA by D1 and D2 dopamine receptors. Pollack AE, Wooten GF. Brain Res Mol Brain Res; 1992 Jan; 12(1-3):111-9. PubMed ID: 1312196 [Abstract] [Full Text] [Related]
7. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes. Jiang HK, McGinty JF, Hong JS. Brain Res; 1990 Jan 15; 507(1):57-64. PubMed ID: 1967976 [Abstract] [Full Text] [Related]
8. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors. Reid MS, O'Connor WT, Herrera-Marschitz M, Ungerstedt U. Brain Res; 1990 Jun 11; 519(1-2):255-60. PubMed ID: 1975763 [Abstract] [Full Text] [Related]
9. Topography of dopamine behaviours mediated by D1 and D2 receptors revealed by intrastriatal injection of SKF 38393, lisuride and apomorphine in rats with a unilateral 6-hydroxydopamine-induced lesion. Fletcher GH, Starr MS. Neuroscience; 1987 Feb 11; 20(2):589-97. PubMed ID: 2953990 [Abstract] [Full Text] [Related]
11. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density. LaHoste GJ, Marshall JF. Synapse; 1992 Sep 11; 12(1):14-26. PubMed ID: 1357762 [Abstract] [Full Text] [Related]
12. D1 priming enhances both D1- and D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats. Pollack AE, Thomas LI. Pharmacol Biochem Behav; 2010 Jan 11; 94(3):346-51. PubMed ID: 19800912 [Abstract] [Full Text] [Related]
13. Role of a 35 kDa fos-related antigen (FRA) in the long-term induction of striatal dynorphin expression in the 6-hydroxydopamine lesioned rat. Bronstein DM, Ye H, Pennypacker KR, Hudson PM, Hong JS. Brain Res Mol Brain Res; 1994 May 11; 23(3):191-203. PubMed ID: 7914658 [Abstract] [Full Text] [Related]
14. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats. Robertson GS, Fine A, Robertson HA. Brain Res; 1991 Jan 25; 539(2):304-11. PubMed ID: 1675908 [Abstract] [Full Text] [Related]
15. The effects of dopamine D-1 and D-2 receptor subtype agonists on nigrostriatal opioid dynorphin and enkephalin immunostaining in 6-hydroxydopamine lesioned rats. Jiang HK, Wang JY. Chin J Physiol; 1991 Jan 25; 34(4):413-25. PubMed ID: 1687937 [Abstract] [Full Text] [Related]
16. D1 agonist-induced excitation of substantia nigra pars reticulata neurons: mediation by D1 receptors on striatonigral terminals via a pertussis toxin-sensitive coupling pathway. Martin LP, Waszczak BL. J Neurosci; 1994 Jul 25; 14(7):4494-506. PubMed ID: 7913124 [Abstract] [Full Text] [Related]
17. Pertussis toxin attenuates D2 inhibition and enhances D1 stimulation of adenylate cyclase by dopamine in rat striatum. Olianas MC, Onali P. J Neurochem; 1987 May 25; 48(5):1443-7. PubMed ID: 2951497 [Abstract] [Full Text] [Related]
18. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity. LaHoste GJ, Yu J, Marshall JF. Proc Natl Acad Sci U S A; 1993 Aug 15; 90(16):7451-5. PubMed ID: 8102797 [Abstract] [Full Text] [Related]
19. Microiontophoretic studies of the effects of D-1 and D-2 receptor agonists on type I caudate nucleus neurons: lack of synergistic interaction. Shen RY, Asdourian D, Chiodo LA. Synapse; 1992 Aug 15; 11(4):319-29. PubMed ID: 1354398 [Abstract] [Full Text] [Related]